SCHEMBL9154126

SCHEMBL9154126

Oc1nc(S)c2[nH]cnc2n1.Oc1nc(S)nc2nc[nH]c12

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GDA Q9Y2T3 2/20 0.35
▸ PDPK1 O15530 1/20 0.35
▸ CDK2 P24941 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ PNP P00491 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ MAP3K5 Q99683 1/20 0.31
▸ XDH P47989 1/20 0.31
▸ BRAF P15056 2/20 0.31
▸ ADORA3 P0DMS8 2/20 0.30
▸ ADORA2A P29274 2/20 0.30
▸ ADORA1 P30542 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1724116 0.90 GDA (0.41) GDAPDPK1CDK2DPP4PNP
SCHEMBL833645 0.90 GDA (0.41) GDAPDPK1CDK2DPP4PNP
Xanthine SCHEMBL4966 0.82 GDA (0.44) GDAPDPK1CDK2DPP4PNP
Xanthine SCHEMBL9443819 0.82 GDA (0.44) GDAPDPK1CDK2DPP4PNP
SCHEMBL1275417 0.82 PDPK1 (0.44) GDAPDPK1CDK2DPP4PNP
Xanthine SCHEMBL7044234 0.81 GDA (0.42) GDAPDPK1CDK2DPP4PNP
2,6-Diaminopurine SCHEMBL6839643 0.70 PDPK1 (0.72) GDAPDPK1CDK2DPP4MAP3K5
SCHEMBL612211 0.68 GDA (0.41) GDAPDPK1CDK2DPP4PNP
SCHEMBL29421402 0.68 PDPK1 (0.66) GDAPDPK1CDK2DPP4PNP
SCHEMBL1009011 0.68 XDH (0.56) GDAPDPK1CDK2DPP4XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0586523-A4 DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF UNIV YALE (US) 1995-11-29 — — EP disclosed
EP-0586523-A1 DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF YALE UNIVERSITY (US) 1994-03-16 — — EP disclosed
WO-1992020816-A1 DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF YALE UNIVERSITY (US) 1992-11-26 — — WO disclosed
Send feedback